Drug Profile
B cell lymphoma DNA vaccine - Fresh Tracks Therapeutics
Alternative Names: VaxidLatest Information Update: 14 Sep 2022
Price :
$50
*
At a glance
- Originator Stanford University; Vical
- Developer Fresh Tracks Therapeutics; Stanford University
- Class Cancer vaccines; DNA vaccines; Gene therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Lymphoma